Free Trial

Walgreens Boots Alliance (WBA) Stock Forecast & Price Target

Walgreens Boots Alliance logo
$9.55 +0.20 (+2.14%)
(As of 12/20/2024 05:40 PM ET)

Walgreens Boots Alliance - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
4
Hold
9
Buy
2

Based on 15 Wall Street analysts who have issued ratings for Walgreens Boots Alliance in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 15 analysts, 4 have given a sell rating, 9 have given a hold rating, and 2 have given a buy rating for WBA.

Consensus Price Target

$12.58
31.70% Upside
According to the 15 analysts' twelve-month price targets for Walgreens Boots Alliance, the average price target is $12.58. The highest price target for WBA is $22.00, while the lowest price target for WBA is $7.00. The average price target represents a forecasted upside of 31.70% from the current price of $9.55.
Get the Latest News and Ratings for WBA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Walgreens Boots Alliance and its competitors.

Sign Up

WBA Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
Sell
4 Sell rating(s)
4 Sell rating(s)
4 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$12.58$12.88$14.73$29.17
Forecasted Upside31.70% Upside55.80% Upside69.12% Upside11.24% Upside
Consensus Rating
Reduce
Reduce
Reduce
Hold

WBA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

WBA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Walgreens Boots Alliance Stock vs. The Competition

TypeWalgreens Boots AllianceRetail/Wholesale CompaniesS&P 500
Consensus Rating Score
1.87
2.50
2.51
Consensus RatingReduceHoldModerate Buy
Predicted Upside31.70% Upside28.31% Upside14.54% Upside
News Sentiment Rating
Neutral News

See Recent WBA News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/4/2024Royal Bank of Canada
4 of 5 stars
 Lower TargetSector Perform ➝ Sector Perform$13.00 ➝ $9.00+1.47%
10/23/2024Jefferies Financial Group
2 of 5 stars
 Lower TargetHold ➝ Hold$19.00 ➝ $9.00-4.76%
10/22/2024TD Cowen
5 of 5 stars
 Lower TargetBuy ➝ Buy$16.00 ➝ $14.00+33.97%
10/17/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$9.00 ➝ $10.00-3.57%
10/16/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$7.00 ➝ $8.00-27.73%
10/16/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$7.50 ➝ $10.00-5.84%
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

10/11/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$9.00 ➝ $7.00-22.48%
10/7/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$13.00 ➝ $10.00+13.90%
9/4/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform ➝ Underperform$11.00 ➝ $7.50-15.92%
8/30/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$20.00 ➝ $15.00+63.22%
4/3/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$23.00 ➝ $22.00+18.22%
3/26/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform
3/18/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$23.00 ➝ $22.00+5.72%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/20/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Reduce$27.00 ➝ $20.00-9.46%
10/10/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$31.00 ➝ $25.00+12.26%
8/24/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$33.00 ➝ $30.00+13.04%
2/22/2023Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$45.00+24.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:45 AM ET.


Should I Buy Walgreens Boots Alliance Stock? WBA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, December 15, 2024. Please send any questions or comments about these Walgreens Boots Alliance pros and cons to contact@marketbeat.com.

Walgreens Boots Alliance
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Walgreens Boots Alliance, Inc.:

  • The stock is currently trading at $8.56, which may present a buying opportunity for investors looking for undervalued stocks in the healthcare sector.
  • Walgreens Boots Alliance, Inc. reported a quarterly revenue of $37.50 billion, exceeding analyst expectations of $35.75 billion, indicating strong operational performance.
  • The company has a positive return on equity of 14.23%, suggesting effective management and profitability relative to shareholder equity.
  • Recent analyst upgrades, such as Evercore ISI raising the price target to $10.00, reflect growing confidence in the company's future performance.
  • Walgreens Boots Alliance, Inc. offers a quarterly dividend of $0.25 per share, translating to an annualized yield of approximately 11.68%, which can provide a steady income stream for investors.

Walgreens Boots Alliance
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Walgreens Boots Alliance, Inc. for these reasons:

  • The stock has a negative net margin of 5.85%, indicating that the company is currently operating at a loss, which could be a red flag for potential investors.
  • Multiple analysts have issued sell ratings, with four analysts rating the stock as a sell, suggesting a lack of confidence in the stock's short-term performance.
  • The company has a debt-to-equity ratio of 0.67, which, while not excessively high, indicates that the company is using a moderate amount of debt to finance its operations, potentially increasing financial risk.
  • Walgreens Boots Alliance, Inc. has experienced a significant decline from its one-year high of $27.05, which may indicate underlying issues affecting investor sentiment.
  • The consensus target price among analysts is $12.58, which is significantly higher than the current trading price, suggesting that the stock may be undervalued but also highlighting the uncertainty in achieving that target.

WBA Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Walgreens Boots Alliance is $12.58, with a high forecast of $22.00 and a low forecast of $7.00.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last twelve months. There are currently 4 sell ratings, 9 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" WBA shares.

According to analysts, Walgreens Boots Alliance's stock has a predicted upside of 31.70% based on their 12-month stock forecasts.

Walgreens Boots Alliance has been rated by research analysts at Barclays, Evercore ISI, Jefferies Financial Group, Morgan Stanley, Royal Bank of Canada, TD Cowen, Truist Financial, and UBS Group in the past 90 days.

Analysts like Walgreens Boots Alliance less than other "retail/wholesale" companies. The consensus rating for Walgreens Boots Alliance is Reduce while the average consensus rating for "retail/wholesale" companies is Hold. Learn more on how WBA compares to other companies.


This page (NASDAQ:WBA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners